Spago Nanomedical

Spago Nanomedical is a biotechnology company with expert capabilities in contrast agent- and nanoscale life science research.

Spago Nanomedical develops nanomedical products for cancer diagnostics and treatment. The company’s main activities are focused on developing SpagoPix, a nanomedical contrast agent for MRI, and the therapeutic development project Tumorad, for tumor selective radionuclide treatment.